Please use this identifier to cite or link to this item:
http://localhost:8080/xmlui/handle/123456789/9157
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ali, Sher | - |
dc.contributor.author | Nedvˇedov´a, ˇStˇep´anka | - |
dc.contributor.author | Badshah, Gul | - |
dc.date.accessioned | 2024-12-17T03:19:05Z | - |
dc.date.available | 2024-12-17T03:19:05Z | - |
dc.date.issued | 2022 | - |
dc.identifier.uri | http://localhost:8080/xmlui/handle/123456789/9157 | - |
dc.description.abstract | In this review, the disease and immunogenicity affected by COVID-19 vaccination at the metabolic level are described considering the use of nuclear magnetic resonance (NMR) spectroscopy for the analysis of different biological samples. Consistently, we explain how different biomarkers can be examined in the saliva, blood plasma/serum, bronchoalveolar-lavage fluid (BALF), semen, feces, urine, cerebrospinal fluid (CSF) and breast milk. For example, the proposed approach for the given samples can allow one to detect molecular biomarkers that can be relevant to disease and/or vaccine interference in a system metabolome. The analysis of the given biomaterials by NMR often produces complex chemical data which can be elucidated by multivariate statistical tools, such as PCA and PLS-DA/OPLS-DA methods. Moreover, this approach may aid to improve strategies that can be helpful in disease control and treatment management in the future | en_US |
dc.subject | COVID-19 Immunogenicity Vaccination Nuclear magnetic resonance spectroscopy Chemometrics | en_US |
dc.title | NMR spectroscopy spotlighting immunogenicity induced by COVID-19 vaccination to mitigate future health concerns | en_US |
dc.type | Article | en_US |
Appears in Collections: | VOL 3 2022 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
199-214.pdf | 1.94 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.